Navigation Links
30 Years of Orphan Drug Act, Combined with Science and Advocacy, Reflect Dramatic Progress in a Rare Lung Disease, Pulmonary Hypertension Association Says

Silver Spring, MD (PRWEB) May 08, 2013

Pulmonary hypertension (PH), a rare and life-threatening lung disease, has gone from rapidly fatal to treatable with nine drugs developed in just the past 20 years, a phenomenal record for a rare condition. Growth in the understanding and treatment of PH reflects the dramatic progress possible since the passage of the Orphan Drug Act 30 years ago, according to the Pulmonary Hypertension Association (PHA),

Progress in PH compares strongly to that of the other 7,000 rare diseases in this country. Only three other conditions have as many treatments as PH or more. Most, in fact, have one or none at all. Whereas physicians treating PH once delivered terminal diagnoses, they now expect their patients to live with their condition. Many patients survive for years – even 10 to 20 years or more – with proper PH treatment.

The development of treatments has also solved one old problem while creating a new one – we are now better able to treat this disease than we are to diagnose it. PHA is running a new campaign, Sometimes it's PH, to promote early diagnosis mainly through educating and information medical professionals. (

Scientific Backstory

The story behind this progress is a fascinating one which has not been told in the mass media. Its roots stretch back to 1970s when a handful of physician-researchers fascinated by the pulmonary vascular system each worked independently in different cities. In the 80s, this group first worked together on building the original PH registry in the U.S. through the National Heart, Lung and Blood Institute. From there, much collaboration and discovery emerged, gaining momentum, and creating a fast-growing segment of medicine treating this disease.

The physician-researchers in the vanguard of making PH treatable -- members of PHA’s Scientific Leadership Council -- remain in the field. They will be meeting with other cardiologists and pulmonologists May 19-21 at the American Thoracic Society conference in Philadelphia. The 30 years of the Orphan Drug Act will also be celebrated by the National Organization for Rare Disorders at an event in Washington, D.C., May 14.

PHA can provide information on the history of the Orphan Drug Act, advocacy for rare disease policy and research, interviews with leading physicians and scientists in this field and access to patients who have survived long-term with PH.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Breast Cancer Treatment Side Effects May Last for Years
3. Life expectancy and healthy life years in the European Union, 2008-2010
4. Measles Outbreaks in 2011 Were Worst in 15 Years: CDC
5. 16 years old is peak risk for teens misusing prescription drugs
6. NAMS journal Menopause reflects on the WHI 10 years later
7. After 25 years, World No Tobacco Day is making an impact
8. Elreg Distributors Ltd. Celebrates 32 Years in Business
9. Weight-Loss Surgery Cuts Heart Risk 7 Years Later: Study
10. For Combat Vets, Brain Injury Symptoms Can Last Years
11. New Electronic Cigarette Free Trial Kit Adds More Years to Smokers Life by Making it Easy to Quit Smoking
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Volpara ... breast density assessment and enterprise analytics solutions, here at the 101st Annual ... Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements of ...
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... Sikka ... New York Dental Meeting. Their Ecosystem empowers dentists to make complex business decisions by ... the booth will receive a free fee survey with 10 procedures customized by zip ...
(Date:11/30/2015)... ... , ... Scott Newman MD, FACS of New York’s Advanced ... in the New York City area to utilize the new, non-invasive SculpSure™ Laser ... treatment for fat loss in the abdomen, flanks, and other areas that is ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... today released the results of a survey of educational needs for pharmacists worldwide. ... a growing global demand for high quality online and face-to-face education for pharmacists ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announces the Unstoppable Swappables, a household invention that provides an economical and easy ... a year and is growing at 2.6%," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , November 30, 2015 Mexico Healthcare ... and Life Sciences Report 2015 . --> Pharmaboardroom releases ... . Latin America , a country of ... , a country of over 122 million people. --> ... healthcare, pharmaceuticals, or life sciences insights into the second largest pharma ...
(Date:11/29/2015)... AMSTERDAM , Nov. 29, 2015   Royal ... data driven radiology solutions at the 2015 Radiological Society ... December 4 at McCormick Place in Chicago ... will experience the company,s broad portfolio of integrated ... Management solutions to increase clinical performance, improve workflow and ...
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
Breaking Medicine Technology: